{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:45:23Z","timestamp":1770813923319,"version":"3.50.1"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1001\/jamaoncol.2016.7123","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T16:33:52Z","timestamp":1500568432000},"page":"1140","source":"Crossref","is-referenced-by-count":2,"title":["Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer"],"prefix":"10.1001","volume":"3","author":[{"given":"Per Eystein","family":"L\u00f8nning","sequence":"first","affiliation":[{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway2Department of Oncology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/oncology.jamanetwork.com\/ama\/content_public\/journal\/oncology\/936421\/jamaoncology_lnning_2017_le_160048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T20:24:29Z","timestamp":1683318269000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2016.7123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2016.7123","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}